Literature DB >> 21972272

Clozapine: dangerous orphan or neglected friend?

Saeed Farooq, Mark Taylor.   

Abstract

Evidence concerning the superior efficacy and effectiveness of clozapine has not fully informed routine clinical practice. This is possibly because of the perception that clozapine is a dangerous therapeutic agent. Clozapine use may actually promote longevity, and earlier use of clozapine in adequate dosages represents a neglected therapeutic opportunity in this age of stagnated antipsychotic innovation.

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21972272     DOI： 10.1192/bjp.bp.110.088690

Source DB:  PubMed          Journal:  Br J Psychiatry        ISSN： 0007-1250            Impact factor:   9.319


  24 in total

1.  Using treatment response to subtype schizophrenia: proposal for a new paradigm in classification.

Authors:  Saeed Farooq; Ofer Agid; George Foussias; Gary Remington
Journal:  Schizophr Bull       Date:  2013-09-17       Impact factor: 9.306

2.  Pathway to clozapine use: a comparison between a patient cohort from New Zealand and a cohort from the United Kingdom.

Authors:  Amanda J Wheeler; Celia L Feetam; Jeff Harrison
Journal:  Clin Drug Investig       Date:  2014-03       Impact factor: 2.859

Review 3.  Neuropsychiatric expression and catatonia in 22q11.2 deletion syndrome: An overview and case series.

Authors:  Nancy J Butcher; Erik Boot; Anthony E Lang; Danielle Andrade; Jacob Vorstman; Donna McDonald-McGinn; Anne S Bassett
Journal:  Am J Med Genet A       Date:  2018-05-19       Impact factor: 2.802

4.  Predictors of Treatment-Resistant and Clozapine-Resistant Schizophrenia: A 12-Year Follow-up Study of First-Episode Schizophrenia-Spectrum Disorders.

Authors:  Sherry Kit Wa Chan; Hei Yan Veronica Chan; William G Honer; Tarun Bastiampillai; Yi Nam Suen; Wai Song Yeung; Ming Lam; Wing King Lee; Roger Man King Ng; Christy Lai Ming Hui; Wing Chung Chang; Edwin Ho Ming Lee; Eric Yu Hai Chen
Journal:  Schizophr Bull       Date:  2021-03-16       Impact factor: 9.306

5.  Clozapine prescribing in the UK: views and experience of consultant psychiatrists.

Authors:  Tongeji E Tungaraza; Saeed Farooq
Journal:  Ther Adv Psychopharmacol       Date:  2015-04

Review 6.  Clozapine and therapeutic drug monitoring: is there sufficient evidence for an upper threshold?

Authors:  Gary Remington; Ofer Agid; George Foussias; Larissa Ferguson; Krysta McDonald; Valerie Powell
Journal:  Psychopharmacology (Berl)       Date:  2012-11-22       Impact factor: 4.530

Review 7.  Clozapine for psychotic disorders in adults with intellectual disabilities.

Authors:  Muhammad Ayub; Khalid Saeed; Tariq A Munshi; Farooq Naeem
Journal:  Cochrane Database Syst Rev       Date:  2015-09-23

Review 8.  Chemotherapy for Hodgkin's lymphoma in a patient receiving clozapine for treatment-resistant schizophrenia: use of the Mental Capacity Act 2005.

Authors:  Florence Elizabeth Chamberlain; Nicholas Walsh; Jan Falkowski
Journal:  BJPsych Bull       Date:  2015-12

9.  Quo Vadis Clozapine? A Bibliometric Study of 45 Years of Research in International Context.

Authors:  Francisco López-Muñoz; Javier Sanz-Fuentenebro; Gabriel Rubio; Pilar García-García; Cecilio Álamo
Journal:  Int J Mol Sci       Date:  2015-09-23       Impact factor: 5.923

10.  Clozapine reinitiation following a "red result" secondary to chemotherapy.

Authors:  Tariq Munshi; Mir Mazhar; Tariq Hassan
Journal:  Neuropsychiatr Dis Treat       Date:  2013-08-27       Impact factor: 2.570
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.